Trials / Withdrawn
WithdrawnNCT02081989
Renal Denervation in Diabetes.
Effect of Renal Sympathetic Denervation on Glycemic Status Independent of Blood Pressure-lowering.
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Monash University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Renal denervation (the use of radio waves to oblate the renal artery) has been shown to be an effective treatment for high blood pressure. It is currently being tested in heart failure patients and we would now like to look it its effects on diabetes. We therefore plan to enrol 20 participants with type II diabetes into this study. Half will undergo renal denervation in addition to their standard care and the other half will act as controls and only receive standard care. Treatment allocation will be randomly assigned. All participants will undergo screening (including a physical exam, blood tests, ultrasounds and a muscle biopsy). All patients will have follow up tests (including physical exams and blood tests) 1, 3 and 6 months later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Renal denervation | Renal denervation |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-03-07
- Last updated
- 2016-06-01
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02081989. Inclusion in this directory is not an endorsement.